Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Quivive Pharma Inc
Profile last edited on: 9/26/23      CAGE: 84KG6      UEI: FYG1F4U7FJE9

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2015
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

17532 Marengo Drive
Rowland Heights, CA 91748
   (858) 336-2334
   N/A
   www.quivivepharma.com
Location: Single
Congr. District: 38
County: Los Angeles

Public Profile

With an impressively experienced Executive Team, Quivive ('kee-veev'), assembled Advisory Board and key consultants, Quivive Pharma Inc Pharma is addressing the opioid crisis with a safer generation of abuse-deterrent analgesic products

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$1
Phase II Dollars
$1,393,153
Total Awarded
$1,393,154

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NIH $1,904,562
Project Title: Abuse-deterrence and prevention of respiratory depression by an oral opioid analgesic and doxapram combination

Key People / Management

  John Hsu -- CEO Founder

  Peter Rix -- Chief Scientific Officer

  Gary Seelhorst -- Senior VP Business Development

  Peter Weinstein -- General Counsel

Company News

There are no news available.